Patrick A Cosgrove

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

End Stage Renal Disease

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Nature communications

Beckman Research Institute, City of Hope

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Beckman Research Institute, City of Hope Oct 31 2017

United States

Staff Scientist :: Medical Oncology & Research Therapeutics

Amgen Inc

United States

Senior Research Associate :: Comparative Biology and Safety Science Laboratory

Publications

Elena Farmaki, Aritro Nath, Rena Emond, Kimya L Karimi, Vince K Grolmusz, Patrick A Cosgrove, Andrea H Bild
ONC201/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast cancer. eLife 12 (2023)
Aritro Nath, Patrick A Cosgrove, Hoda Mirsafian, Elizabeth L Christie, Lance Pflieger, Benjamin Copeland, Sumana Majumdar, Mihaela C Cristea, Ernest S Han, Stephen J Lee, Edward W Wang, Sian Fereday, Nadia Traficante, Ravi Salgia, Theresa Werner, Adam L Cohen, Philip Moos, Jeffrey T Chang, David D L Bowtell, Andrea H Bild
Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer. Nature communications 12 (1) (2021)
Jason I Griffiths, Pierre Wallet, Lance T Pflieger, David D Stenehjem, Xuan Liu, Patrick A Cosgrove, Neena A Leggett, Jasmine A McQuerry, Gajendra Shrestha, Maura Rossetti, Gemalene Sunga, Philip J Moos, Frederick R Adler, Jeffrey T Chang, Sunil Sharma, Andrea H Bild
Circulating immune cell phenotype dynamics reflect the strength of tumor-immune cell interactions in patients during immunotherapy. Proceedings of the National Academy of Sciences of the United States of America 117 (27) (2020)